Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification

[REGULATORY ACTION]

Jan 7, 2026 · Johnson & Johnson · Johnson & Johnson Ottava · New Brunswick

Failure Mode

REGULATORY ACTION

Event Date

Jan 7, 2026

Primary Entity

Johnson & Johnson

Robotic Platform

Johnson & Johnson Ottava

Jurisdiction / Location

New Brunswick

Audit Standard

Physical State Verified

Incident Abstract & Audit Findings

J&J submitted OTTAVA soft-tissue robotic surgical system to FDA for de novo classification. IDE clinical data in upper-abdomen procedures.

System & Fleet Architecture

Operating Manufacturer

Johnson & JohnsonView Manufacturer

Hardware Platform

Johnson & Johnson Ottava

Operational Sectors

Physical AI / Robotics

Primary Sources & Evidentiary Filings

  • https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration

    https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration

Related Incidents & Failure Precedents

6 records on file

Incident Context & FAQ

What happened in Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification?

J&J submitted OTTAVA soft-tissue robotic surgical system to FDA for de novo classification. IDE clinical data in upper-abdomen procedures.

When did this incident occur?

The incident is recorded as occurring on January 7, 2026 on the DEPLOY registry. The date reflects the underlying real-world event, not the registry record's creation date.

What robot was involved in Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification?

Johnson & Johnson Ottava by Johnson & Johnson is the recorded robot involved in this incident at New Brunswick.

Has anyone responded to Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification?

No responses to this incident are recorded on the DEPLOY registry. Operators, manufacturers, or affected parties can submit responses to the editorial team; absence is not a guarantee no response was issued.

What is the current status of Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification?

This incident is an active record on the DEPLOY registry; no retraction or correction has been issued.